A detailed history of Ogorek Anthony Joseph transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ogorek Anthony Joseph holds 648 shares of GILD stock, worth $43,215. This represents 0.02% of its overall portfolio holdings.

Number of Shares
648
Previous 811 20.1%
Holding current value
$43,215
Previous $65,000 27.69%
% of portfolio
0.02%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$71.58 - $87.29 $11,667 - $14,228
-163 Reduced 20.1%
648 $47,000
Q4 2023

Feb 09, 2024

SELL
$73.27 - $83.09 $2.58 Million - $2.92 Million
-35,169 Reduced 97.75%
811 $65,000
Q3 2023

Oct 19, 2023

SELL
$73.94 - $80.67 $6,358 - $6,937
-86 Reduced 0.24%
35,980 $2.7 Million
Q2 2023

Aug 03, 2023

SELL
$76.01 - $86.7 $373,133 - $425,610
-4,909 Reduced 11.98%
36,066 $2.78 Million
Q1 2023

May 03, 2023

SELL
$77.31 - $88.08 $391,729 - $446,301
-5,067 Reduced 11.01%
40,975 $3.4 Million
Q4 2022

Jan 30, 2023

SELL
$62.32 - $89.47 $13,897 - $19,951
-223 Reduced 0.48%
46,042 $3.95 Million
Q3 2022

Oct 20, 2022

BUY
$59.54 - $68.01 $21,434 - $24,483
360 Added 0.78%
46,265 $2.85 Million
Q2 2022

Jul 21, 2022

BUY
$57.72 - $65.01 $68,455 - $77,101
1,186 Added 2.65%
45,905 $2.84 Million
Q1 2022

Apr 26, 2022

BUY
$57.92 - $72.58 $360,899 - $452,245
6,231 Added 16.19%
44,719 $2.66 Million
Q4 2021

Jan 18, 2022

BUY
$64.88 - $73.64 $1,686 - $1,914
26 Added 0.07%
38,488 $2.79 Million
Q3 2021

Oct 27, 2021

BUY
$67.69 - $73.03 $473 - $511
7 Added 0.02%
38,462 $2.69 Million
Q2 2021

Jul 14, 2021

BUY
$63.47 - $69.35 $66,008 - $72,124
1,040 Added 2.78%
38,455 $2.65 Million
Q1 2021

Apr 26, 2021

BUY
$60.0 - $68.46 $601,140 - $685,900
10,019 Added 36.57%
37,415 $2.42 Million
Q4 2020

Jan 20, 2021

BUY
$56.65 - $64.55 $51,551 - $58,740
910 Added 3.44%
27,396 $1.6 Million
Q3 2020

Nov 02, 2020

BUY
$62.1 - $78.08 $1.64 Million - $2.07 Million
26,486 New
26,486 $1.67 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $83.6B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Ogorek Anthony Joseph Portfolio

Follow Ogorek Anthony Joseph and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ogorek Anthony Joseph , based on Form 13F filings with the SEC.

News

Stay updated on Ogorek Anthony Joseph with notifications on news.